A Healthy Weight Intervention for Family Stress during the Early Phases of ALL Treatment: NOURISH-ALL
ALL 治疗早期针对家庭压力的健康体重干预:NOURISH-ALL
基本信息
- 批准号:10808650
- 负责人:
- 金额:$ 20.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-15 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:Acute Lymphocytic LeukemiaAddressAdverse eventBehavior TherapyBehavioralBehavioral ModelCancer ControlCancer SurvivorChildChild HealthChildhood Acute Lymphocytic LeukemiaChildhood Cancer TreatmentChronicClinicalClinical TrialsCognitiveCognitive TherapyConduct Clinical TrialsCoping SkillsDataDevelopment PlansDiagnosisDietary intakeDisease-Free SurvivalDisparityDoseEatingEducationEligibility DeterminationEnrollmentEnvironmentFamilyFeedbackFutureGlucocorticoidsGoalsHealthHealth PromotionHealth behaviorInterventionInterviewKnowledgeMalignant Childhood NeoplasmMalignant NeoplasmsMentorshipModelingNewly DiagnosedObesityOutcomeParticipantPatientsPharmaceutical PreparationsPhasePhysical activityPlayPreparationProcessPrognosisProtocols documentationResearchResearch PersonnelRoleScientistSepsisShapesStressStress and CopingStructureSurvival RateSystemTargeted ResearchTestingTimeToxic effectTrainingTreatment ProtocolsTreatment outcomeUnhealthy DietWeightWeight GainWorkYouthacceptability and feasibilityarmbehavior changecancer diagnosiscareercareer developmentclinical practicecopingdesignefficacy testingefficacy trialevidence baseexcessive weight gainexperiencefamily structurefamily supportfollow-uphealthy weighthigh riskimprovedintervention refinementleukemia treatmentmultidisciplinarypatient engagementpatient orientedphysical inactivitypilot testpreventpreventive interventionrecruitrelapse riskresearch and developmentretention ratesedentaryskill acquisitionskillsstress managementstressorsurvivorshiptherapy developmenttreatment disparityweight gain prevention
项目摘要
PROJECT SUMMARY/ABSTRACT
Excessive weight gain leading to obesity is common during the early phases of pediatric acute lymphoblastic
leukemia (ALL) treatment, and results in higher risk of relapse, lower event-free survival rates, and more adverse
events during treatment. Yet, effective preventive interventions for excessive weight gain during the early phases
of ALL treatment are lacking. Aligned with NCI priorities, the long-term objective of this work is to mitigate weight-
related disparities in pediatric cancer treatment outcomes. Guided by the ORBIT Model of Behavioral
Intervention Development, the goal of this proposal is to adapt, refine, and pilot test a family-based health
promotion intervention that aims to curb excessive weight gain among youth with ALL by integrating support for
family coping with stress during the early phases of ALL treatment. Given that ALL is most prevalent in young
children, families play an essential role in shaping youth’s health behaviors during treatment. In Aim 1a, the PI
and her mentorship team will adapt an existing family-based health promotion intervention (NOURISH-T) to meet
the specific needs of families of youth in the early phases of ALL treatment (NOURISH-ALL). Adaptations will
incorporate family systems and cognitive behavioral intervention components to support healthy family coping
with diagnosis and treatment stress. Additional, patient-centered adaptations regarding intervention content and
delivery will be informed by semi-structured input from families and youth with ALL (n=10 at minimum) and
multidisciplinary clinical experts (n=6 at minimum) until thematic saturation is reached. In Aim 1b, the
investigative team will iteratively refine the NOURISH-ALL intervention through sequential testing with families
and youth with ALL (n=5 at minimum) and structured participant feedback. Intervention refinement will be
ongoing until >80% feasibility and acceptability ratings are achieved or until n=10 families complete the
intervention and provide structured feedback. In Aim 2, the adapted and refined NOURISH-ALL intervention will
be pilot tested in a single arm trial with 20 newly recruited families of youth in the early phases of ALL treatment.
The research team will assess key components of participant engagement to inform the future, fully powered
clinical trial, including recruitment rate, retention at treatment completion, and intended intervention dose
received. By incorporating tailored strategies for health promotion during the early phases of ALL treatment, the
proposed study seeks to shift clinical practice paradigms to prevent weight-related disparities in treatment
outcomes. This K08 will provide opportunities for the PI to acquire skills and knowledge in: (1) the early phases
of ALL treatment, (2) scientific adaptation and refinement of family-based behavior change interventions, and (3)
the conduct of clinical trials focused on behavior change interventions. The research and career development
plan, supported by a multidisciplinary team of experts in a rich academic environment, will support the PI’s
transition to independence as a cancer control scientist who possesses the skills and expertise needed to adapt
evidence-based behavior change interventions to the pediatric cancer treatment context.
项目摘要/摘要
在小儿急性淋巴细胞的早期阶段,体重增加过度会导致肥胖至肥胖很常见
白血病(全)治疗,并导致复发的高风险,无事件的生存率较低,并且不利
治疗期间的事件。
在所有治疗中都缺乏与NCI的优先级相符的,这是减轻体重的长期目标
小儿癌症治疗结果的相关差异。
干预开发是该提案的目的是适应,完善和试点测试基于家庭的健康
促进干预措施旨在通过整合支持堡堡的支持堡
在所有治疗的早期阶段,家庭应对压力。
儿童,家庭在AIM 1A的治疗过程中起着重要的作用。
她的指导团队将适应现有的基于家庭的健康促进间隔(Nourish-T)以满足
在所有治疗的早期阶段(nourish-all),青年家庭的特定需求。
结合家庭系统和认知行为干预,以支持健康的家庭应对
诊断和治疗压力。
分娩将通过家庭和年轻人的半结构化意见来告知所有人(至少n = 10)和
多学科临床专家(n = 6至少),直到在AIM 1B中达到主题饱和。
调查团队将迭代完善与家人的nourish所有干预序列测试
所有的年轻人(至少为n = 5)和结构化参与者的反馈将进行。
一直持续到达到80%的可行性和可接受性等级,或直到n = 10个家庭完成
间隔并提供AIM 2中的结构化反馈
在所有治疗的早期阶段,在一次手臂试验中进行试点测试。
研究小组将评估参与者参与的关键组成部分,以告知未来,完全动力
临床试验,包括招聘率,治疗完成时保留率以及预期的干预剂量
通过在所有治疗的早期阶段加入量身定制的健康策略。
支撑研究试图改变临床实践范例,以防止与体重相关的治疗差异
结果。
在所有治疗中,(2)基于家庭行为变化干预措施的科学适应和改进,以及(3)
临床的行为集中在行为改变研究和职业发展。
在丰富的学术环境中的多学科专家团队的支持下,计划将支持PI的
作为癌症控制科学家的过渡到独立性,他拥有适应所需的技能和专业知识
基于证据的行为变化干预对小儿癌症的沟渠环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carolyn R Bates其他文献
Carolyn R Bates的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 20.93万 - 项目类别:
Trispecific CAR-T cells targeting CD19, CD20 and CD22 to treat B-cell malignancies
靶向 CD19、CD20 和 CD22 的三特异性 CAR-T 细胞治疗 B 细胞恶性肿瘤
- 批准号:
10735096 - 财政年份:2023
- 资助金额:
$ 20.93万 - 项目类别:
Development and Validation of a Patient-Reported Measure Assessing Chimeric Antigen Receptor (CAR) T-Cell Therapy-Related Side Effects
开发和验证患者报告的评估嵌合抗原受体 (CAR) T 细胞治疗相关副作用的方法
- 批准号:
10436573 - 财政年份:2022
- 资助金额:
$ 20.93万 - 项目类别:
Socioeconomic determinants of childhood cancer outcomes in a large contemporary cohort
当代大型队列中儿童癌症结果的社会经济决定因素
- 批准号:
10559542 - 财政年份:2022
- 资助金额:
$ 20.93万 - 项目类别:
Socioeconomic determinants of childhood cancer outcomes in a large contemporary cohort
当代大型队列中儿童癌症结果的社会经济决定因素
- 批准号:
10339085 - 财政年份:2022
- 资助金额:
$ 20.93万 - 项目类别: